Back to top

Image: Bigstock

WellCare Health Partners Mission Health to Improve Offerings

Read MoreHide Full Article

WellCare Health Plans, Inc’s wholly owned subsidiary, Wellcare of North Carolina recently has inked a deal with Mission Health. The agreement is aimed at providing better Medicaid and Medicare services in North Carolina.

WellCare Health has always been keen on improving its offerings and serving patients better through several organic and inorganic growth strategies. These moves are likely to be appreciated by investors. In the last one year, shares of the company have gained 49% compared with the industry’s rally of 41%.

 

 

Mission Health consists of six hospitals, numerous outpatient and surgery centers, post-acute care provider, CarePartners and long-term acute care provider, Asheville Specialty Hospital. As of Jun 30, 2017, WellCare Health served nearly 33,000 Medicare prescription drug plan members in North Carolina. Hence the collaboration is likely to result in a wide and vast health care system that would better serve the people in North Carolina.

In addition, Mission Health is one of the leading dedicated Level II trauma center in North Carolina. The alliance is likely to help Mission Health in providing WellCare Health’s members healthier lives.

Since both the organizations recognize and appreciate a collaborative and fair agreement, this deal is likely to benefit both the parties. Mission Health is expected to continue providing the highest level of services to the communities WellCare Health serves.

Zacks Rank and Key Picks

WellCare Health currently holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Investors interested in this space can also consider stocks like Aetna, Inc , Anthem, Inc. and Amedisys Inc (AMED - Free Report) . All the three stocks carry a Zacks Rank #2.

Aetna’s earnings surpassed expectations in each of the last four quarters with an average beat of nearly 19%.

Anthem delivered positive surprises in three of the last four quarters with an average beat of 8.6%.

Amedisys delivered positive surprises in three of the last four quarters with an average beat of 7.2%

Zacks' 10-Minute Stock-Picking Secret

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

But here's something even more remarkable: You can master this proven system without going to a single class or seminar. And then you can apply it to your portfolio in as little as 10 minutes a month.

Learn the secret >>


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


Amedisys, Inc. (AMED) - $25 value - yours FREE >>